Pharmaceutical Technology North America, December 2019 (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2019
Volume 43
Issue 12

Click the title above to open the Pharmaceutical Technology December 2019 issue in an interactive PDF format.

External Link - ezine_Watermark_PT1219_L2.pdf

Download Issue PDF
Articles in this issue
Applying Lessons Learned from the Semiconductor Industry
Applying Lessons Learned from the Semiconductor Industry
Visualization Enhances Facility Design
Visualization Enhances Facility Design
columns_225.jpg
Bio Diol and IEX Columns
BD Intevia™ with Azure Blue Label_225.jpg
Two-step Disposable Autoinjector
1_GiroNEX_CubePlus_for batch manufacturing_225.jpg
Cube Plus for Pharmaceutical Manufacturing
ROSS VM-600_225.jpg
Triple Shaft Mixer with Powder Induction Manifold
Fighting the Good Fight
Managing Excipient Interactions
Managing Excipient Interactions
‘Polling’ All the Way
The Challenges for Regulators in the Digital Age
Tackling Solubility in Drug Development
Tackling Solubility in Drug Development
Meeting E&L Expectations
Meeting E&L Expectations
Mitigating Risk to Secure the Drug Supply Chain
Mitigating Risk to Secure the Drug Supply Chain
December2019_DOE_Text_Image.jpg
DOE Gains Ground in Biopharmaceutical Development
Pharmaceutical Technology North America, December 2019 (PDF)
Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Beckman Coulter Life Sciences Launches Modular Spectral Flow Cytometry Module, First of Its Kind in Industry

Feliza Mirasol
March 28th 2025
Article

The CytoFLEX mosaic Spectral Detection Module offers up to 88 channels for detection.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Sherwin-Williams to Showcase Next-Gen Coatings for Pharma Cleanrooms at INTERPHEX 2025

Feliza Mirasol
March 28th 2025
Article

Sherwin-Williams’ advanced coating systems are designed to ensure safety, sterility, and efficiency in pharma manufacturing environments.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Issues Warning Letter to Aspen Biopharma Labs for API Manufacturing Deviations

Feliza Mirasol
March 27th 2025
Article

In the latest of a series of warning letters to India-based API manufacturers, FDA issued a warning letter to Aspen for deviations in CGMP in the production of APIs.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

BIO Survey: Tariffs May Reduce Access, Delay Innovation, Create Red Tape

Patrick Lavery
March 27th 2025
Article

The Biotechnology Innovation Organization’s new membership survey said that 90% of US biotech companies rely on imported components for at least half of their FDA-approved products.